Emrusolmin restores hippocampal synaptic and transcriptional plasticity as well as spatial memory in a mouse model for Alzheimer’s disease, when given orally before or after the onset of pathology. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Emrusolmina and Emrusolmine. Its PubChem CID is 44608289.
Emrusolmin
| CAS No | 882697-00-9 |
|---|---|
| Molecular Formula | C16H11BrN2O2 |
| Molecular Weight | 343.17 g/mol |
| Synonyms | 5-(1,3-benzodioxol-5-yl)-3-(3-bromophenyl)-1H-pyrazole |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Emrusolmin restores hippocampal synaptic and transcriptional plasticity as well as spatial memory in a mouse model for Alzheimer's disease, when given orally before or after the onset of pathology.
The listed CAS number is 882697-00-9.
The listed molecular formula is C16H11BrN2O2.
The listed molecular weight is 343.17 g/mol.
5-(1,3-benzodioxol-5-yl)-3-(3-bromophenyl)-1H-pyrazole.
The source lists Emrusolmina and Emrusolmine.